Grimes & Company’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,768	Closed	-$88.8K	–	325
2023 Q1	$88.8K	Buy	9,768 +89	+0.9%	+$1.26K	﹤0.01%	285
2022 Q4	$114K	Buy	9,679 +49	+0.5%	+$864	﹤0.01%	277
2022 Q3	$204K	Buy	9,630 +116	+1%	+$3.13K	0.01%	253
2022 Q2	$231K	Buy	9,514 +145	+2%	+$4.93K	0.01%	247
2022 Q1	$467K	Buy	9,369 +1,537	+20%	+$75.9K	0.02%	204
2021 Q4	$550K	Sell	7,832 -767	-9%	-$64.6K	0.03%	195
2021 Q3	$802K	Buy	8,599 +543	+7%	+$51.6K	0.03%	169
2021 Q2	$810K	Buy	8,056 +560	+7%	+$54.6K	0.04%	166
2021 Q1	$699K	Buy	7,496 +2,799	+60%	+$284K	0.03%	169
2020 Q4	$388K	Buy	4,697 +121	+3%	+$10.3K	0.02%	202
2020 Q3	$393K	Buy	4,576 +22	+0.5%	+$2.56K	0.03%	190
2020 Q2	$424K	Buy	4,554 +1,183	+35%	+$65.2K	0.03%	185
2020 Q1	$96K	Buy	3,371 +714	+27%	+$27.8K	0.01%	221
2019 Q4	$110K	Buy	+2,657	New	+$58.2K	0.01%	259